Key Finding:
Gastric cancers with high expression of NY-ESO-1 have a high expression of immune related genes and a T-cell inflamed signature (TIS) score, which predicts benefit from anti-PD-1 treatment.
– Caris Life Sciences
Key Finding:
Gastric cancers with high expression of NY-ESO-1 have a high expression of immune related genes and a T-cell inflamed signature (TIS) score, which predicts benefit from anti-PD-1 treatment.